Skip to main content
. 2020 Apr 29;136(2):157–170. doi: 10.1182/blood.2020004850

Figure 3.

Figure 3.

Effect of current WHO classification criteria on OS of patients with SF3B1-mutated MDS. (A) OS of patients with SF3B1-mutated MDS according to the presence of single-lineage (blue curve, n = 267) or multilineage (red curve, n = 171) dysplasia (P = .4). (B) OS of patients with SF3B1-mutated MDS according to bone marrow blasts <5% (blue curve, n = 341) or ≥5% (red curve, n = 85) (P < .001).